Modulation of Inflammatory Gene Transcripts in Psoriasis Vulgaris: Differences Between Ustekinumab and Etanercept

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2019.01.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pss41 - Secukinumab Significantly Reduces Psoriasis-Related Work Impairment and Indirect Costs Compared to Ustekinumab and Etanercept in Tunisia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pss42 - Secukinumab Significantly Reduces Psoriasis-Related Work Impairment and Indirect Costs Compared to Ustekinumab and Etanercept in Morocco

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Transforming Growth Factor-Β1 Gene Polymorphism in Psoriasis Vulgaris

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2018English

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Psoriasis: Therapie Mit Ustekinumab Ist Langzeitig Erfolgreich

hautnah dermatologie
2013English

The Relationship Between Human Leukocyte Antigen-Cw6 Allele and Psoriasis Vulgaris

Dermatology Reports
Dermatology
2019English

Efficacy and Safety of Ustekinumab in Patients With Psoriasis and Psoriatic Arthritis

Clinical pharmacology and therapy
2018English

Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2019English

Lepra Vulgaris. History of Psoriasis

Journal of the Turkish Academy of Dermatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy